Agile Therapeutics Inc. Announces Definitive Merger Agreement with Insud Pharma, S.L.

Agile Therapeutics, Inc. (“Agile”) (OTCQB: AGRX), a women’s healthcare company, announces that it has entered into a definitive merger agreement (“Merger Agreement”) with Insud Pharma, S.L. (“Insud”) a global pharmaceutical group based in Spain with a 45 year track record and a presence in over 50 countries, pursuant to which Insud, through its US subsidiary, Exeltis Project, Inc. (“Exeltis”), will acquire Agile for $1.52 per share in cash net of assumed liabilities and estimated transaction costs for an approximate total enterprise value of $45 million. Agile Therapeutics is a women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women.

Read the full article: Agile Therapeutics Inc. Announces Definitive Merger Agreement with Insud Pharma, S.L. //

Source: https://www.globenewswire.com/news-release/2024/06/26/2904429/30925/en/Agile-Therapeutics-Inc-Announces-Definitive-Merger-Agreement-with-Insud-Pharma-S-L.html

Scroll to Top